Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Reaches Settlement

Core Viewpoint - Grabar Law Office is investigating claims on behalf of shareholders of Lifecore Biomedical, Inc. regarding potential breaches of fiduciary duties by certain officers and directors [1] Group 1: Investigation and Claims - Lifecore Biomedical, Inc. shareholders who held shares before October 7, 2020, can seek corporate reforms, return of funds, and a court-approved incentive award at no cost [2] - A federal securities class action against Lifecore Biomedical and certain officers has reached a settlement, alleging that the defendants made materially false and misleading statements about the company's business and operations [3] Group 2: Allegations and Settlement - The class action complaint alleges that Lifecore maintained deficient internal controls over financial reporting, leading to inaccurate financial statements that required restatement [3] - The company and individual defendants entered into an agreement in principle to settle the class action in November 2025 [4]